PGS PGS ASA

PGS ASA: Settlement of Long-term Incentive Plans

PGS ASA: Settlement of Long-term Incentive Plans

Reference is made to the joint stock exchange announcements on 11 June 2024 by PGS ASA ("PGS" or the “Company”, OSE: PGS) and TGS ASA ("TGS", OSE: TGS) regarding the combination of the two companies (the "Merger") to establish the premier energy data company being declared unconditional with an expected closing date on 1 July 2024. Reference is further made to the long-term incentive plans issued by PGS dated 21 April 2021, 27 April 2022 and 26 April 2023 (the “LTI Plans”) pursuant to which employees in PGS and its subsidiaries have been granted Performance based Restricted Stock Units (“PRSUs”).

Pursuant to the LTI Plans and the Merger plan, all outstanding PRSUs awarded under the LTI Plans to employees and primary insiders in the Company and its subsidiaries have settled as calculated by multiplying the number of eligible PRSUs and the volume weighted average price of the PGS share on the Oslo Stock Exchange on 27 June 2024.

Primary insider notifications pursuant to the Market Abuse Regulation article 19 are attached.

Contacts:

Bård Stenberg, VP IR & Corporate Communication

Mobile:

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act section 5-12.



Attachment



EN
28/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PGS ASA

Ahmed Ben Salem ... (+3)
  • Ahmed Ben Salem
  • Marc Lavaud
  • Thijs Berkelder

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 07/04/2024

Sartorius is set to outperform the underlying biopharmaceutical market based on higher exposure to novel biologics and its focus on single-use components. Destocking is likely to end soon but the changing ordering pattern could distort order intake as KPI and organic growth should recover faster. In our view, the expected cut to its FY 2024 guidance is already largely reflected in the share price. Based on the expected turnaround, we have upgraded to Outperform with a new target price...

Ahmed Ben Salem ... (+3)
  • Ahmed Ben Salem
  • Marc Lavaud
  • Thijs Berkelder

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 04/07/2024

Sartorius is set to outperform the underlying biopharmaceutical market based on higher exposure to novel biologics and its focus on single-use components. Destocking is likely to end soon but the changing ordering pattern could distort order intake as KPI and organic growth should recover faster. In our view, the expected cut to its FY 2024 guidance is already largely reflected in the share price. Based on the expected turnaround, we have upgraded to Outperform with a new target price...

Ahmed Ben Salem ... (+3)
  • Ahmed Ben Salem
  • Baptiste Lebacq
  • Thijs Berkelder

ODDO : Trump / Biden: Drill Baby Drill vs IRA? Not such a clear-cut eq...

>Elections for the no.1 oil producer on 5 November - The first debate between Trump and Biden on CNN last week did not address the questions/challenges surrounding energy. At the end of this very unique year (almost half of the global population will go to, or has already been to, the ballot box), all eyes will be on the US elections (5 November 2024), a country that has become the world’s no.1 oil producer (production growth of 19% under the Biden mandate, see char...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch